Wolfe Research analyst Gal Munda initiates coverage on Procore Technologies (NYSE:PCOR) with a Peer Perform rating.
Why Lyra Therapeutics Stock Is Down 93% Today
Lyra Therapeutics shares are trading lower by 93% to $0.30 during Monday's session. The company announced the ENLIGHTEN 1 trial did not meet its primary endpoint.